|
C反应蛋白与白蛋白比值对肝硬化食管胃底静脉曲张出血患者术后再出血的影响
|
Abstract:
目的:分析C反应蛋白/白蛋白比值对肝硬化食管胃底静脉曲张出血患者术后再出血的影响因素。方法:回顾性收集2018年5月至2022年12月在青岛大学附属医院就诊,行精准食管胃底静脉曲张断流术治疗的70例肝硬化食管胃底静脉曲张破裂出血患者,根据术前三天内的C反应蛋白/白蛋白比值,将患者分为高CAR组和低CAR组,比较二组患者术后1年内的再出血率,并分析患者术后1年内再出血的危险因素。结果:高CAR组患者1年内再出血率为36.8% (7/19),低CAR组患者1年内再出血率为60.8% (31/51),两组差异无统计学意义(Log-rank P = 0.120),多因素结果显示门静脉血栓(HR = 2.19, 95%CI: 1.15~4.20, P = 0.018)是患者术后1年内再出血的独立危险因素。结论:CAR对肝硬化食管胃底静脉曲张出血患者术后1年内再出血无明显临床意义,门静脉血栓是患者术后1年内再出血的独立危险因素。
Objective: To investigate the effect of C-reactive protein/albumin ratio on postoperative rebleeding in cirrhotic patients with esophageal and gastric varices bleeding. Methods: The retrospective cohort study included 70 patients who underwent ESVD at the affiliated Hospital of Qingdao University from May 2018 to December 2022. According to the C-reactive protein/albumin ratio within three days before surgery, the patients were divided into high-CAR group and low-CAR group, The rebleeding rate within 1 year after surgery was compared between the two groups, and the risk factors for rebleeding within 1 year after surgery were analyzed. Results: The rebleeding rate within 1 year after surgery was 36.8% (7/19) in the high CAR group and 60.8% (31/51) in the low CAR group, with no statistical significance between the two groups (Log-rank P = 0.120).Multivariable analysis identified that portal vein thrombosis (HR = 2.19, 95%CI: 1.15~4.20, P = 0.018) was an independent risk factor for rebleeding within 1 year after surgery. Conclusions: The data suggested that CAR have no significant clinical significance in reducing the risk of rebleeding at one year. Furthermore, PVT was an independent factor with a significant influence on the risk for rebleeding in these patients.
[1] | Zacharias, A.P., Jeyaraj, R., Hobolth, L., Bendtsen, F., Gluud, L.L. and Morgan, M.Y. (2018) Carvedilol versus Traditional, Non-Selective Beta-Blockers for Adults with Cirrhosis and Gastroesophageal Varices. Cochrane Database of Systematic Reviews, No. 10, CD011510. https://doi.org/10.1002/14651858.cd011510.pub2 |
[2] | 周文杰, 项琪, 李江涛, 等. 不同时机内镜下食管胃底静脉曲张精准断流术联合内镜下硬化术治疗食管胃底静脉曲张破裂出血的临床效果[J]. 中国当代医药, 2023, 30(7): 70-7276. |
[3] | 韩嫒萍, 高原, 刘长虹. 肝硬化患者营养状况相关指标的评估[J]. 系统医学, 2023, 8(20): 194-198. |
[4] | 曾文新, 曾红科, 柳学, 等. C反应蛋白与白蛋白比值在急性A型主动脉夹层手术患者预后预测中的价值[J]. 中华急诊医学杂志, 2016, 25(6): 764-768. |
[5] | Costa, D., Simbrunner, B., Jachs, M., Hartl, L., Bauer, D., Paternostro, R., et al. (2021) Systemic Inflammation Increases across Distinct Stages of Advanced Chronic Liver Disease and Correlates with Decompensation and Mortality. Journal of Hepatology, 74, 819-828. https://doi.org/10.1016/j.jhep.2020.10.004 |
[6] | Sporea, I. (2011) Value of Transient Elastography for the Prediction of Variceal Bleeding. World Journal of Gastroenterology, 17, 2206-2210. https://doi.org/10.3748/wjg.v17.i17.2206 |
[7] | 中华医学会消化内镜学分会食管胃静脉曲张内镜诊断与治疗学组. 肝硬化门静脉高压消化道静脉曲张内镜下组织胶注射治疗专家共识(2022, 长沙) [J]. 中华胃肠内镜电子杂志, 2022, 9(4): 193-206. |
[8] | 中华医学会消化内镜学分会食管胃静脉曲张内镜诊断与治疗学组. 肝硬化门静脉高压食管胃静脉曲张内镜下硬化治疗专家共识(2022, 长沙) [J]. 中华胃肠内镜电子杂志, 2022(4): 181-192. |
[9] | Yan, L., Wang, L., Yao, J., Yang, Y., Mao, X., Yue, W., et al. (2020) Total Bile Acid-to-Cholesterol Ratio as a Novel Noninvasive Marker for Significant Liver Fibrosis and Cirrhosis in Patients with Non-Cholestatic Chronic Hepatitis B Virus Infection. Medicine, 99, e19248. https://doi.org/10.1097/md.0000000000019248 |
[10] | Voiosu, A., Wiese, S., Voiosu, T., Bendtsen, F. and Møller, S. (2017) Bile Acids and Cardiovascular Function in Cirrhosis. Liver International, 37, 1420-1430. https://doi.org/10.1111/liv.13394 |
[11] | Aydin, M., Dirik, Y., Demir, C., Tolunay, H. and Demir, H. (2021) Can We Reduce Oxidative Stress with Liver Transplantation? Journal of Medical Biochemistry, 40, 351-357. https://doi.org/10.5937/jomb0-29983 |
[12] | Yotti, R., Ripoll, C., Benito, Y., Catalina, M.V., Elízaga, J., Rincón, D., et al. (2017) Left Ventricular Systolic Function Is Associated with Sympathetic Nervous Activity and Markers of Inflammation in Cirrhosis. Hepatology, 65, 2019-2030. https://doi.org/10.1002/hep.29104 |
[13] | Mehta, G., Gustot, T., Mookerjee, R.P., Garcia-Pagan, J.C., Fallon, M.B., Shah, V.H., et al. (2014) Inflammation and Portal Hypertension—The Undiscovered Country. Journal of Hepatology, 61, 155-163. https://doi.org/10.1016/j.jhep.2014.03.014 |
[14] | 郭健文, 姚维敏, 李永春, 等. C反应蛋白与中性粒细胞/淋巴细胞比值与肝硬化患者感染及短期生存率的相关性研究[J]. 中国医师杂志, 2017, 19(9): 1353-1357. |
[15] | Levine, J.A., Han, J.M., Wolska, A., Wilson, S.R., Patel, T.P., Remaley, A.T., et al. (2020) Associations of Glyca and High-Sensitivity C-Reactive Protein with Measures of Lipolysis in Adults with Obesity. Journal of Clinical Lipidology, 14, 667-674. https://doi.org/10.1016/j.jacl.2020.07.012 |
[16] | Hamaguchi, Y., Kaido, T., Okumura, S., Kobayashi, A., Shirai, H., Yagi, S., et al. (2017) Impact of Skeletal Muscle Mass Index, Intramuscular Adipose Tissue Content, and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation. Transplantation, 101, 565-574. https://doi.org/10.1097/tp.0000000000001587 |
[17] | Takamori, S., Toyokawa, G., Shimokawa, M., Kinoshita, F., Kozuma, Y., Matsubara, T., et al. (2018) The C-Reactive Protein/Albumin Ratio Is a Novel Significant Prognostic Factor in Patients with Malignant Pleural Mesothelioma: A Retrospective Multi-Institutional Study. Annals of Surgical Oncology, 25, 1555-1563. https://doi.org/10.1245/s10434-018-6385-x |
[18] | 许国玺, 林高枫, 王怀帅, 等. C反应蛋白与白蛋白比值对结直肠癌患者术后早期吻合口漏的预测价值[J]. 中国医师杂志, 2020, 22(6): 818-821. |
[19] | 田山, 曹英豪, 廖斐, 等. 术前C反应蛋白与前白蛋白比值预测结直肠癌患者术后预后的价值[J]. 中华消化杂志, 2021, 41(3): 195-199. |
[20] | Metwally, K., Fouad, T., Assem, M., et al. (2018) Predictors of Spontaneous Bacterial Peritonitis in Patients with Cirrhotic Ascites. Journal of Clinical and Translational Hepatology, 6, 372-376. https://doi.org/10.14218/JCTH.2018.00001 |
[21] | 周嘉敏, 唐源, 李红纳. ALBI、NLR、CRP联合诊断肝硬化合并细菌性腹膜炎的临床价值[J]. 云南医药, 2024, 45(1): 65-68. |
[22] | Cagin, Y., Bilgic, Y., Berber, İ., Yildirim, O., Erdogan, M., Firat, F., et al. (2019) The Risk Factors of Portal Vein Thrombosis in Patients with Liver Cirrhosis. Experimental and Therapeutic Medicine, 17, 3189-3194. https://doi.org/10.3892/etm.2019.7300 |